ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.090
+0.010 (0.93%)
At close: Apr 2, 2026, 4:00 PM EDT
1.030
-0.060 (-5.50%)
After-hours: Apr 2, 2026, 6:32 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $26.93 million as of April 2, 2026. Its market cap has increased by 213.18% in one year.
Market Cap
26.93M
Enterprise Value
29.66M
1-Year Change
213.18%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $26.93M, a decrease of -66.12%. That is a compound annual growth rate of -20.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 27.70M | -46.53% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 28.37M |
| Tvardi Therapeutics | 28.33M |
| CEL-SCI | 28.08M |
| Exicure | 26.71M |
| Senti Biosciences | 26.67M |
| Lixte Biotechnology Holdings | 26.57M |
| Serina Therapeutics | 26.11M |
| Passage Bio | 25.92M |